Catalyst Wire Dossier Catalyst Wire Dossier

rDEN3-3'Ddelta30 Dengue virus vaccine

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rDEN3-3'Ddelta30 Dengue virus vaccine, covering 2013-01-03 to 2013-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults [Phase 1]

See pricing